SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma board to consider Un-Audited Financial Results

22 Jan 2014 Evaluate

Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 06, 2014, to consider the Un-Audited Financial Results of the Company for the quarter ended December 31, 2013 (Q3).

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1587.40 -6.50 (-0.41%)
07-Jul-2026 10:58 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1911.35
Dr. Reddys Labs. 1365.50
Cipla 1463.60
Zydus Lifesciences 1166.35
Lupin 2495.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: